The aim of the study. The primary objective of this study was to determine the differences in the incidence of respiratory infections and septic episodes in patients who underwent early percutaneous tracheotomy (ET) and in patients who underwent translaryngeal intubation i.e late tracheotomy (LT). Secondary objectives were to determine the differences in the early mortality of patients, duration of mechanical ventilation and length of Intensive care unit (ICU) stay. Materials and methods. The study included 72 surgical and trauma patients older than 18 years of age, treated at the ICU of the University Clinical Hospital Mostar who had undergone translaryngeal intubation and were mechanically ventilated for at least 48 hours. The basic criterion for inclusion in the study was expected duration of mechanical ventilation of at least 14 days. Forty-eight hours after enrollment, patients were randomly divided into two groups. The first group of patients underwent ET after 2-4 days of mechanical ventilation; the second group underwent LT if they exhibited longer episodes of hypoxemia after 15 days. Results. The ET group of patients spent less time in mechanical ventilation and ICU. The ET group had a lower rate of VAS pneumonia (p=0.137), sepsis episodes (p=0.029) and mortality rate (p=0.056). Conclusion. The results of our study support ET being performed 2-4 days from the start of mechanical ventilation. Despite a lack of power, we found significant benefits of ET regarding the incidence of pneumonia, sepsis, hospital mortality, duration of mechanical ventilation and length of ICU stay
INTRODUCTION
The optimal method of treating the airways and implementing the process of mechanical ventilation in patients who are unable to breathe spontaneously, has been the object of clinicians' interest for almost a hundred years. (1) In comparison with translaryngeal intubation, the benefits of early percutaneous tracheotomy (ET) include: prevention of serious injury to the larynx, greater airway safety, decreased airway resistance, facilitated pulmonary hygiene, and oral cavity care which can reduce the incidence of developing lung infections, help to facilitate the weaning process of mechanical ventilation, and greater mobility and comfort of patients. (2) Although the rate of tracheotomy procedures, in particular percutaneous tracheotomy, has, according to the literature, increased by 200% in recent years, the analysis of major databases still continues to show an unbalanced approach in regards to the time required to perform tracheotomy procedures, early or late, and the conflicting and inconsistent results relating to the incidence of nosocomial infection, cardiac complications, duration of treatment, duration of mechanical ventilation, and survival rate of patients. (3) Adesina et al. point out the reduced number of days on the ventilator and shorter treatment in the Intensive care unit (ICU) as benefits of ET; however, their study did not report a decrease in hospital mortality rate. (4) Shorter treatment in ICUs is cited in other studies as well, (5-7) while Mahafza et al. and Rumbak et al. reported a decrease in mortality rate as a benefit of ET too. (8, 9) In a study by Brook et al., the reduction of hospital costs is cited to be one of the benefits, which is not to be disregarded. (10) The majority of previous studies is retrospective, time spent performing ET in the cited studies was too big (two to ten days), while non-homogeneous groups of patients made it difficult to interpret the results. Most studies did not precisely explain how randomization of patients was done, or the criteria according to which the patients were assessed for expected duration of mechanical ventilation. The primary objective of this study was to determine the differences in the incidence of respiratory infections and septic episodes in patients who underwent ET and in patients who underwent translaryngeal intubation i.e. LT. Secondary objectives were to determine the differences in early mortality of patients, duration of mechanical ventilation and length of ICU stay.
MATERIALS AND METHODS
The study included 72 surgical and trauma patients older than 18 years of age, treated at the ICU of the University Clinical Hospital Mostar who underwent translaryngeal intubation and were mechanically ventilated for at least 48 hours. The study was approved by the Ethics Committee of the University Clinical Hospital Mostar (3108/13,29.05.2013). The basic criterion for inclusion in the study was the expected duration of mechanical ventilation for at least 14 days based on the diagnosis of patients SOFA score >5, APACHE II scores >10, PaO2 ≤60 mmHg with FiO2 0.5 and PEEP of at least 8 cm H2O. Patients who had already undergone tracheotomy, patients with a history of anatomical deformity of the neck, or suffering from hematologic malignancies and patients who were diagnosed with a respiratory infection within the first 48 h of mechanical ventilation were all excluded from the study. Due to the specific condition of patients, informed written consent for participation in the study was signed by a member of the patient's immediate family. Forty-eight hours after enrollment, patients were randomly divided into two groups. The first group of patients underwent early tracheotomy (ET) after 2-4 days of mechanical ventilation, while the patients in the second group were ventilated through the endotracheal tube. The patients in the second group underwent late tracheotomy (LT) if they exhibited longer episodes of hypoxemia after 15 days, identified as PaO2 <60 mmHg with FiO2 0.6 and PEEP = 8 cm. Percutaneous dilatational tracheotomy was performed in the ICU. Over the treatment course, all complications related to tracheotomy were noted and classified as: 1. intraoperative: minor or significant bleeding, difficult tracheotomy tube placement (i.e., requiring >2 attempts at insertion during primary placement procedure), hypoxia (oxygen saturation of<90% for 60 sec) and arrhythmia. 2. post-operative: inflammatory changes around the stoma, pneumothorax, subcutaneous emphysema, tracheoesophageal fistula, cannula displacement, and the need for cannula replacement. All patients were assessed according to the APACHE II score upon admittance to the ICU, while SOFA scores were determined 48 h after the start of ventilation. All patients were mechanically ventilated with ventilator settings (tidal volume 6-7ml/kg, peak pressure <35 cm, PEEP >5 cm H2O) in accordance with good clinical practice. The process of weaning from the ventilator was done according to the algorithm of gradually reducing ventilator support during pressure support ventilation (PSV). At the start of the study, every patient was classified according to: age, gender, primary diagnosis, type of surgical procedure (abdominal or urological, neurological, vascular), emergency or elective surgical procedure. In addition a complete hematological and biochemical analysis and surveillance cultures of nasal and rectum swabs were performed. All patients underwent qualitative and quantitative analysis of bronchial secretions using the bronchoalveolar lavage technique 48 hours after the start of mechanical ventilation. Ventilator associated pneumonia (VAP) was diagnosed based on standardized criteria: body temperature <38 or >36, purulent bronchial secretions, new lung infiltrate observed on X-ray, qualitative and quantitative microbiological analysis of the bronchial secretion obtained by bronchoalveolar lavage and laboratory diagnostics (leucocyte count, C-reactive protein, etc). (11) Septic episodes were diagnosed based on: clinical symptoms, laboratory results, hemodynamic parameters and microbiological analysis in accordance with usual clinical practice, as well as on established criteria for the diagnosis of sepsis: temperature >38°C or <36°C, heart rate >90 beats per minute, respiratory rate >20 breaths per minute, abnormal white blood cell count >12,000/mm3 or <4,000/ mm3 or >10% bands, occurrence of hypoperfusion, hypotension and oliguria. (12) The occurrence of cardiac ischemia and arrhythmias was detected by constant electrocardiographic (ECG) monitoring. Microbiological analysis of bronchial secretions was done every three days in patients included in the study. For patients diagnosed with hospital ventilator associated pneumonia, the frequency of performing microbiological analysis of the bronchial secretion depended on the microbiological lab results and clinical disease course. The dynamics of carrying out hematological, biochemical and other microbiological analysis was determined by the clinical condition of the patient. Microbiological analyses were performed at the Institute of Microbiology and Molecular Diagnostics of the University Clinical Hospital Mostar in a way that pathogens were isolated and identified from the samples along with determining their potential resistance to certain antibiotics according to the antibiogram. Hematological and biochemical results were collected at the Institute of Laboratory Diagnostics of the University Clinical Hospital Mostar. The following criteria were noted for every patient in both groups: the number of days on mechanical ventilation, the total number of ICU days, and the treatment outcome. The study reported difficulties in weaning the patients from the ventilator and incidences of re-intubation of patients. Bronchoscopic examination of the larynx and trachea was performed within 1 to 5 days of removal of the cannula or endotracheal tube and any probable functional or anatomical injuries were recorded. We also noted clinical symptoms of dysphagia, dysphonia, dyspnea, etc. Data were collected by the physicians from the Department of Anesthesiology and Reanimation and Intensive Care of the University Clinical Hospital Mostar, while percutaneous tracheostomy was performed by the same and experienced ICU attending physician. A software system SPSS forWindows(v ersion17.0,SPSSInc., Chicago, Illinois, USA) and MicrosoftExcel (version Office 2007,Redmond,WA,USA) was used for statistical analysis of the obtained data. Results of nominal characteristics are expressed as n (%), Chi-square test was used to test significant differences (if lack of expected frequency occurred the Fisher's exact test was used). Kolmogorov-Smirnov test was used to test concurrency of interval characteristics with normal distribution. Characteristics which did not deviate from the normal distribution are expressed as mean and standard deviation (M±SD), while t-Test was used to test significance of the difference between the means of two independent samples. Characteristics which deviated from the normal distribution are expressed as median and interquartile range (C [IQ]) while MannWhitney test was used to test significance of the difference. The level of significance was set at 0.050 while values which could not be expressed to three decimal places are reported as p<0.001.
RESULTS
Distribution of patients according to tracheotomy and other analyzed parameters ispresented in Table 1 . There was no statistically significant difference between the observed groups in regards to gender (p=0.148) and median age (p=0.386) and APACHE II score (p=0.472). There wasno statistically significant difference between the groups in the distribution of patients by predicted mortality rates according to APACHE II score (p=0.187). The difference found in the mean value of the SOFA score between the observed groups is not statistically significant (p=0.213). The difference found in the incidence of pneumonia among patients from the observed groups is not statistically significant (p=0.128), but patients who underwent LT were found to be more likely to develop pneumonia than those who underwent ET (OR=2.000; 95% CI: 0.816-4.902). Sepsis is more likely to occur in patients who had LT than in patients who had ET (OR=2.479; 95% CI: 0.995-6.176). The difference found is statistically significant (p=0.049). The ET group showed less mortality, the difference is statistically significant (p=0.028). According to APACHE II score values, 57.9% of patients who had ET are in the third mortality group. Distribution of patients by group and outcome shows that the portion of patients who died is 44.7% in the group of patients who underwent ET and 69.0% in the group of patients who underwent LT. The actual mortality is much higher in the group of patients who had LT. Length of ICU stay and duration of mechanical ventilation according to the groups are presented in Table 2 .
The patients who had LT stayed in the ICU longer, and the difference found in the median length of ICU stay between the observed groups is statistically significant (p<0.001). Patients who had LT were on mechanical ventilation longer, and the difference found in the median duration of mechanical ventilation between the observed groups is statistically significant (p<0.001). Adverse events associated with tracheotomy are indicated in Table 3 . Only one patient (2.38%) in the late tracheotomy group experienced an adverse event.
DISCUSSION
The benefits of tracheotomy include: improved patient comfort due to reduction of oropharyngeal and laryngeal stimulation (and possibly less damage to the larynx), less need for sedation, improvement of pulmonary toilet, lower work of breathing, faster weaning from mechanical ventilation, lower risk of ventilator-associated pneumonia, and perhaps shorter duration of mechanical ventilation. By preventing microaspiration of secretions, tracheotomy might reduce VAP and septic episodes. Based on available data, we believe it is reasonable to perform early tracheotomy in all patients who require prolonged mechanical ventilation. In most studies and meta analyses a common limitation is heterogeneity of studied populations, as well as methodological variability of the study population, such as time of ET, inclusion and exclusion criteria, tracheotomy techniques etc. Defining and predicting the need for prolonged ventilation has been a major methodological problem and challenge. The first question that arises is the follow- Most of the meta analysis and RCT trials published on ET have found no important benefits with ET. There was no difference in hospital mortality and there was not enough evidence to support ET with regard to the incidence of VAP. In most studies ET was significantly associated with a decreased length of ICU and hospital stay and length of mechanical ventilation. The literature on this topic is difficult to interpret because of varying definition of early tracheotomy 0 to 7 days and inhomogeneous groups of patients, different inclusion and exclusion criteria, randomization techniques, different weaning protocols and because some of the studies are retrospective.
The most important limitation of our study is the small number of included patients, leading to underpowered (unsupported) results. In addition, the study is limited by being a single -center study.
On the other hand, we believe that our study is free of the main methodological problems. We have a homogenous population in terms of pathology and in terms of severity of illness because we used objective inclusion criteria in the study populations and we precisely defined the timing for performing ET.
The results of our study support ET performed 2 -4 days from the start of mechanical ventilation in regards to the length of mechanical ventilation and length of ICU stay. Despite the lack of power, we found significant benefits of early tracheotomy regarding the incidence of pneumonia, sepsis and hospital mortality.
